Nuwellis (NUWE) Cash from Investing Activities (2011 - 2026)
Nuwellis' (NUWE) quarterly Cash from Investing Activities came in at -$284000.0 in Q1 2026, down 2466.67% on a QoQ basis from $12000.0 in Q4 2025.
Nuwellis (NUWE) Cash from Investing Activities (2011 - 2026) Analysis & Trends
Nuwellis (NUWE) has 16 years of Cash from Investing Activities data on file, last reported at -$284000.0 in Q1 2026.
- Quarterly Cash from Investing Activities changed N/A year-over-year to -$284000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$374000.0 (down 1106.45% YoY) and the FY2025 annual result came in at -$90000.0, down 50.0% from the prior year.
- Cash from Investing Activities declined to -$284000.0 in Q1 2026, from $12000.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $14.8 million in Q4 2022 to a low of -$284000.0 in Q1 2026.
- A 5-year average of $914000.0 and a median of -$22500.0 in 2022 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2023 — Cash from Investing Activities soared 4763.64% — and 2025, when it sank 712.5%.
- Tracing NUWE's Cash from Investing Activities over 5 years: stood at $14.8 million in 2022, then tumbled by 99.76% to $36000.0 in 2023, then plunged by 163.89% to -$23000.0 in 2024, then jumped by 152.17% to $12000.0 in 2025, then sank by 2466.67% to -$284000.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$284000.0 (Q1 2026), $12000.0 (Q4 2025), and -$98000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Nuwellis | 203,898.38 | -3.72 Mn | 1.50 Mn | -9,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9,000.00 |
| Jun 30, 2026 | -9,000.00 |
| Mar 31, 2026 | -284,000.00 |
| Mar 31, 2026 | -284,000.00 |
| Dec 31, 2025 | 12,000.00 |
| Dec 31, 2025 | 12,000.00 |
| Sep 30, 2025 | -98,000.00 |
| Sep 30, 2025 | -98,000.00 |
| Jun 30, 2025 | -4,000.00 |
| Jun 30, 2025 | -4,000.00 |
| Dec 31, 2024 | -23,000.00 |
| Dec 31, 2024 | -23,000.00 |
| Sep 30, 2024 | 16,000.00 |
| Sep 30, 2024 | 16,000.00 |
| Jun 30, 2024 | -24,000.00 |
| Jun 30, 2024 | -24,000.00 |
| Mar 31, 2024 | -29,000.00 |
| Mar 31, 2024 | -29,000.00 |
| Dec 31, 2023 | 36,000.00 |
| Dec 31, 2023 | 36,000.00 |